Medcura Inc (Medcura), is a medical device company that provides products for the treatment of acute wounds. The company's products include surgical hemostasis products, military and trauma products, consumer products, among others. Its consumer products include woundgel and woundwash. Medcura markets its products under the brands LifeGel, LifeCoat, LifeSheet, LifeFib, Life Patch, LifeFoam, LifeDust, LifePutty, RapidSeal, SealIt, WashIt. It's products are used in clinical settings, routine lacerations, nosebleeds, traumatic injuries, surgical bleeds, burns and diabetic ulcers among others. Medcura is headquartered in Riverdale, Maryland, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Medcura Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Medcura Inc Company Overview
- Medcura Inc Company Snapshot
- Medcura Inc Pipeline Products and Ongoing Clinical Trials Overview
- Medcura Inc - Pipeline Analysis Overview
- Medcura Inc - Key Facts
- Medcura Inc - Major Products and Services
- Medcura Inc Pipeline Products by Development Stage
- Medcura Inc Pipeline Products Overview
- Hemogrip Foam
- Hemogrip Foam Product Overview
- LifeDust
- LifeDust Product Overview
- LifeFoam
- LifeFoam Product Overview
- LifeGel
- LifeGel Product Overview
- Surgicura
- Surgicura Product Overview
- Trauma Gel-e
- Trauma Gel-e Product Overview
- Medcura Inc - Key Competitors
- Medcura Inc - Key Employees
- Medcura Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Medcura Inc, Recent Developments
- Sep 25, 2024: Medcura's Hemostatic Agent Lifegel Wins 2024 Spine Technology Award
- Jan 12, 2023: Medcura receives breakthrough device designation for its LifeGel absorbable surgical hemostat
- Sep 01, 2022: Injectable non-thrombin foam increases survival rates for severe internal bleeding in recent research study
- Jul 12, 2021: Medcura launches a new class of high-performance, antibacterial hemostats
- Apr 07, 2021: Medcura publishes successful results from clinical study
- Feb 23, 2021: Medcura expands Internal Hemostat Program with a follow-on grant from the U.S. Military
- Dec 19, 2019: gel-e changes its name to Medcura
- Oct 31, 2019: Continued expansion of gel-e's consumer products label
- Apr 03, 2019: Successful first use of gel-e in a surgical model
- Jan 21, 2019: gel-e expands patent estate
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Medcura Inc Pipeline Products and Ongoing Clinical Trials Overview
- Medcura Inc Pipeline Products by Equipment Type
- Medcura Inc Pipeline Products by Indication
- Medcura Inc, Key Facts
- Medcura Inc, Major Products and Services
- Medcura Inc Number of Pipeline Products by Development Stage
- Medcura Inc Pipeline Products Summary by Development Stage
- Hemogrip Foam - Product Status
- Hemogrip Foam - Product Description
- LifeDust - Product Status
- LifeDust - Product Description
- LifeFoam - Product Status
- LifeFoam - Product Description
- LifeGel - Product Status
- LifeGel - Product Description
- Surgicura - Product Status
- Surgicura - Product Description
- Trauma Gel-e - Product Status
- Trauma Gel-e - Product Description
- Medcura Inc, Key Employees
- Glossary
- Medcura Inc Pipeline Products by Equipment Type
- Medcura Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Devon IT Inc.
- EO2 Concepts
- Coloplast Corp
